BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22808525)

  • 1. Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome.
    Vergès B; Avignon A; Bonnet F; Catargi B; Cattan S; Cosson E; Ducrocq G; Elbaz M; Fredenrich A; Gourdy P; Henry P; Lairez O; Leguerrier AM; Monpère C; Moulin P; Vergès-Patois B; Roussel R; Steg G; Valensi P; ;
    Arch Cardiovasc Dis; 2012 Apr; 105(4):239-53. PubMed ID: 22808525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome.
    Vergès B; Avignon A; Bonnet F; Catargi B; Cattan S; Cosson E; Ducrocq G; Elbaz M; Fredenrich A; Gourdy P; Henry P; Lairez O; Leguerrier AM; Monpère C; Moulin P; Vergès-Patois B; Roussel R; Steg G; Valensi P;
    Diabetes Metab; 2012 Apr; 38(2):113-27. PubMed ID: 22209680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical appraisal of the 'Consensus statement on care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of an acute coronary syndrome'.
    Danchin N
    Arch Cardiovasc Dis; 2012 Apr; 105(4):193-5. PubMed ID: 22633292
    [No Abstract]   [Full Text] [Related]  

  • 4. [Management of hyperglycemic/diabetic patient during and in the immediate follow-up of an acute coronary syndrome].
    Vergès B
    Presse Med; 2016 Oct; 45(10):865-870. PubMed ID: 27374266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
    Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
    Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes and baseline glucose are associated with inflammation, left ventricular function and short- and long-term outcome in acute coronary syndromes: role of the novel biomarker Cyr 61.
    Winzap P; Davies A; Klingenberg R; Obeid S; Roffi M; Mach F; Räber L; Windecker S; Templin C; Nietlispach F; Nanchen D; Gencer B; Muller O; Matter CM; von Eckardstein A; Lüscher TF
    Cardiovasc Diabetol; 2019 Oct; 18(1):142. PubMed ID: 31672144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of admission HbA(1c) level in diabetic patients with acute coronary syndrome.
    Chan CY; Li R; Chan JY; Zhang Q; Chan CP; Dong M; Yan BP; Lam YY; Yu CM
    Clin Cardiol; 2011 Aug; 34(8):507-12. PubMed ID: 21717470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Admission fasting plasma glucose is associated with in-hospital outcomes in patients with acute coronary syndrome and diabetes: findings from the improving Care for Cardiovascular Disease in China - Acute Coronary Syndrome (CCC-ACS) project.
    Ye N; Yang L; Wang G; Bian W; Xu F; Ma C; Zhao D; Liu J; Hao Y; Liu J; Yang N; Cheng H;
    BMC Cardiovasc Disord; 2020 Aug; 20(1):380. PubMed ID: 32819275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
    Blonde L; Merilainen M; Karwe V; Raskin P;
    Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A large proportion of prediabetes and diabetes goes undiagnosed when only fasting plasma glucose and/or HbA1c are measured in overweight or obese patients.
    Cosson E; Hamo-Tchatchouang E; Banu I; Nguyen MT; Chiheb S; Ba H; Valensi P
    Diabetes Metab; 2010 Sep; 36(4):312-8. PubMed ID: 20627649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of diagnostic criteria to detect undiagnosed diabetes in hyperglycaemic patients with acute coronary syndrome.
    de Mulder M; Oemrawsingh RM; Stam F; Boersma E; Umans VA
    Heart; 2012 Jan; 98(1):37-41. PubMed ID: 21708819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of glycated haemoglobin HbA(1c) for the early detection of diabetes in high-risk subjects.
    Kim KS; Kim SK; Lee YK; Park SW; Cho YW
    Diabet Med; 2008 Aug; 25(8):997-1000. PubMed ID: 18959616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between HbA1c and risk of all-cause hospital admissions among people with Type 2 diabetes.
    Yu D; Simmons D
    Diabet Med; 2013 Dec; 30(12):1407-11. PubMed ID: 23692400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of HbA(1c) levels for diabetes case finding in hospitalized patients with hyperglycemia.
    Greci LS; Kailasam M; Malkani S; Katz DL; Hulinsky I; Ahmadi R; Nawaz H
    Diabetes Care; 2003 Apr; 26(4):1064-8. PubMed ID: 12663574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of acarbose on carotid intima-media thickness in patients with newly diagnosed impaired glucose tolerance or mild type 2 diabetes mellitus: A one-year, prospective, randomized, open-label, parallel-group study in Japanese adults with established coronary artery disease.
    Koyasu M; Ishii H; Watarai M; Takemoto K; Inden Y; Takeshita K; Amano T; Yoshikawa D; Matsubara T; Murohara T
    Clin Ther; 2010 Aug; 32(9):1610-7. PubMed ID: 20974318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensification of diabetes medication and risk for 30-day readmission.
    Wei NJ; Wexler DJ; Nathan DM; Grant RW
    Diabet Med; 2013 Feb; 30(2):e56-62. PubMed ID: 23126686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low 1,5-anhydroglucitol levels are associated with long-term cardiac mortality in acute coronary syndrome patients with hemoglobin A1c levels less than 7.0.
    Ouchi S; Shimada K; Miyazaki T; Takahashi S; Sugita Y; Shimizu M; Murata A; Kadoguchi T; Kato T; Aikawa T; Suda S; Sai E; Hiki M; Iwata H; Kasai T; Miyauchi K; Daida H
    Cardiovasc Diabetol; 2017 Nov; 16(1):151. PubMed ID: 29157245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of hemoglobin A1c and fasting glucose criteria to diagnose diabetes among people with metabolic syndrome and fasting glucose above 100 mg/dL (5.5 mmol/L).
    Liberopoulos EN; Florentin M; Kei A; Mountzouri E; Agouridis A; Elisaf MS
    J Clin Hypertens (Greenwich); 2010 Jul; 12(7):543-8. PubMed ID: 20629819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of acute hyperglycaemia on the in-hospital and long-term prognosis in patients with an acute coronary syndrome--a pilot study.
    Bryniarski L; Terlecki M; Bednarek A; Kocowska M; Szynal S; Kawecka-Jaszcz K
    Kardiol Pol; 2011; 69(8):774-81. PubMed ID: 21850617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.